`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS
`USA, INC., and AKORN INC.1
`Petitioners
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.
`Patent Owners
`___________________
`
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
` ___________________
`
`
`PETITIONER TEVA PHARMACEUTICALS USA, INC.’S
`UPDATED MANDATORY NOTICES PURSUANT
`TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`Petitioner Teva Pharmaceuticals USA, Inc. (“Teva”) hereby files these
`
`Updated Mandatory Notices Pursuant to 37 C.F.R. § 42.8(a)(3) to update the
`
`listing of counsel and service information.
`
`I. LEAD AND BACK-UP COUNSEL
`Teva hereby adds Ralph Wilson Powers III (Reg. No. 63,504) as back-up
`
`counsel:
`
`Ralph Wilson Powers III, Reg. No. 63,504
`tpowers-PTAB@sternekessler.com
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3932
`Tel.: 202-772-8876
`
`Fax: 202-371-2540.
`All previously-listed counsel for Teva remain the same.
`II. SERVICE INFORMATION
`Teva consents to electronic service by email at the email addresses
`
`
`
`gspeier@carlsoncaspers.com, mschuman@carlsoncaspers.com,
`
`IPRCyclosporine@carlsoncaspers.com, tpowers-PTAB@sternekessler.com, and
`
`PTAB@sternekessler.com.
`
`
`
`
`
`
`
`- 1 -
`
`
`
`
`
`Respectfully submitted,
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /
`
` R. Wilson Powers III/
`
`
`Ralph Wilson Powers III, Reg. No. 63,504
`Attorney for Petitioner Teva Pharmaceuticals USA,
`Inc.
`
`- 2 -
`
`
`
`Dated: December 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing PETITIONER TEVA
`
`PHARMACEUTICALS USA, INC.’S UPDATED MANDATORY NOTICES
`
`PURSUANT TO 37 C.F.R. § 42.8(a)(3) and Teva Pharmaceuticals USA, Inc.’s
`
`Updated Power of Attorney were served electronically via e-mail on December 26,
`
`2018, in their entireties on the following counsel of record for Patent Owners:
`
`Dorothy P. Whelan; Michael Kane; Susan
`Morrison Colletti; Robert M. Oakes;
`Jonathan Singer
`FISH & RICHARDSON P.C.
`IPR13351-0008IP1@fr.com
`IPR13351-0008IP2@fr.com
`IPR13351-0008IP3@fr.com
`IPR13351-0008IP4@fr.com
`IPR13351-0008IP5@fr.com
`IPR13351-0008IP6@fr.com
`PTABInbound@fr.com
`
`Alfonso Chan; Joseph DePumpo;
`Michael W. Shore;
`Christopher L. Evans
`SHORE CHAN DEPUMPO LLP
`achan@shorechan.com
`jdepumpo@shorechan.com
`mshore@shorechan.com
`cevans@shorechan.com
`
`Marsha K. Schmidt
`marsha@mkschmidtlaw.com
`
`
`And on the counsel for Petitioners as follows:
`
`Steven W. Parmelee; Michael T. Rosato;
`Jad A. Mills; Wendy L. Devine;
`Douglas H. Carsten
`WILSON SONSINI GOODRICH & ROSATI
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`wdevine@wsgr.com
`dcarsten@wsgr.com
`Attorneys for Mylan Pharmaceuticals Inc.
`
`
`
`
`Michael Dzwonczyk; Azadeh Kokabi;
`Travis Ribar
`SUGHRUE MION, PLLC
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`
`
`
`
`
`Gary J. Speier; Mark D. Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`gspeier@carlsoncaspers.com
`mschuman@carlsoncaspers.com
`IPRCyclosporine@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals
`USA, Inc.
`
`
`
`
`
`Dated: December 26, 2018
`
`
`
`
`
`
`
`
`Respectfully submitted,
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
` /
`
` R. Wilson Powers III/
`
`
`Ralph Wilson Powers III, Reg. No. 63,504
`Attorney for Petitioner Teva Pharmaceuticals USA,
`Inc.
`
`
`
`